GenoVive Announces Formation of Scientific Advisory Board

January 09, 2012


Key Appointments Include Doctors and Experts in the Health and Weight Management Fields from Yale University and the University of North Carolina Who Will Provide Critical Scientific Input and Strategic Insight

GenoVive, a pioneer in DNA-based, all-natural weight management solutions, today announced the formation of a scientific advisory board (SAB) comprised of prominent, multi-disciplinary experts in the fields of health and weight management, nutrigenomics, genetics, biochemistry, clinical psychology, and food science.

The three initial SAB appointments include Dr. Steven H. Zeisel, MD, PhD, Dr. David Katz, MD, MPH, FACPM, FACP, and Dr. Daniel Pomp, MS, PhD, who will guide research activities and provide critical scientific input and strategic insight to GenoVive as the company continues to exploit and leverage current scientific breakthroughs to deliver a comprehensive and personalized weight management solution based on genetic science.

“We are privileged to have these three respected and prominent experts who will help guide our research and lend their specific expertise that will enable us to delve deeper in to the emerging advances of nutritional science and personalized health to bring the best possible weight management solutions to the millions of Americans who are overweight,” said Vic Castellon, founder and CEO, GenoVive LLC.

The GenoVive SAB was established to guide the company’s research activities, seeking out the most innovative and promising research projects for continuing validation of the emerging field of nutrigenomics, which is the study of the effects of foods on gene expression and the role certain genes play in weight gain. The board will also guide the translation of published science into actionable solutions and explore ways to expand its research efforts to accelerate the development of new innovative products.

“Though we once thought that everyone was metabolically the same, we now are learning that there is a great deal of variation in metabolism, much of which is explained by misspellings in our genetic code,” said Dr. Steven Zeisel, who serves as the Director of the Nutrition Research Center at the University of North Carolina. “As the director of a major academic research center that focuses on this specific research, this new science makes it possible to individualize our approach to nutrition. GenoVive is one of the first companies to use this science to improve our treatment of overweight and obesity.”

According to Dr. David Katz, the basic theme of healthful, sensible eating, and sensible approaches to weight control is not up for debate, but the best variation on that theme for an individual is. “We know that genetic variants influence metabolism with important implications for weight control,” said Dr. Katz. “Basing customized weight management approaches on genetic insights is an idea whose time has come. Doing so in a manner that fully respects the fundamentals of healthful eating is responsive to the needs of those frustrated by their weight control struggles and responsible about the use of available science.”

Dr. Pomp adds, “We now know that even our voluntary exercise levels, and how people’s bodies respond to exercise in terms of fat loss and muscle gain, are significantly determined by differences in our genetic code, by variations in our DNA. Personalized nutrition and physical activity plans may be important factors in harmonizing an individual’s diet and exercise for improved health and well being.”

The GenoVive Scientific Advisory Board Members include:

— Steven H. Zeisel, MD, PhD – Chairman: Dr. Steven Zeisel is the Kenan Distinguished University Professor in the Department of Nutrition in the Gillings School of Global Public Health at the University of North Carolina (UNC) at Chapel Hill. He served as chair of the Department of Nutrition at UNC from 1990-2005. He is currently a member of the American Society for Nutrition, the American Society for Parenteral and Enteral Nutrition, the American College of Nutrition and the Society for Pediatric Research.

Dr. Zeisel is also the Director of the UNC Nutrition Research Institute at the newly formed North Carolina Research Campus in Kannapolis, North Carolina. The Institute is also known as a “metabolic chamber” where researchers study foods, activity levels and genes affecting human metabolism. Their findings will help recommend customized diets and exercise plans that support the ultimate goal of individualized nutrition. The Institute’s research endeavors were recently featured in The Charlotte Observer.

He serves on the Federation of American Societies for Experimental Biology (FASEB) Journal
editorial board and is a former member of the Annual Review of Nutrition editorial committee. Dr. Zeisel is a member of the World Cancer Research Fund’s Expert Panel on “Food, Nutrition and the Prevention of Cancer: a Global Perspective.” He serves as the principal investigator on multiple federally funded research projects that focus on human requirements for choline and the effects of this nutrient on brain development. He has authored more than 280 scientific publications.

Dr. Zeisel earned his MD from Harvard Medical School in 1975, was a resident in pediatrics at Yale University from 1975–1977, and earned his PhD in nutrition at the Massachusetts Institute of Technology in 1980.

— David L. Katz, MD, MPH, FACPM, FACP: Dr. David Katz is the founding director of Yale University’s Prevention Research Center. He received his BA from Dartmouth College (1984; Magna Cum Laude); his MD from the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He is a board certified specialist in Preventive Medicine/Public Health, and two-time Diplomate of the American Board of Internal Medicine (1991; 2001). Katz is Director and founder of the Integrative Medicine Center at Griffin Hospital (2000) in Derby, CT, and founder and president of the non-profit Turn the Tide Foundation (

Known internationally for expertise in nutrition, weight management, and chronic disease prevention, as well as integrative care and patient-centered care models, Katz is active in patient care, research, teaching, and public health practice. He established, and formerly directed, one of the nation’s first combined residency programs in Internal Medicine and Preventive Medicine; and served as Director of Medical Studies in Public Health at the Yale School of Medicine for eight years.

Katz has secured nearly $35 million in research funding. He has published over 120 scientific articles & textbook chapters; nearly a thousand newspaper columns; innumerable commentaries and blogs; and 12 books to date. He has consulted on obesity control and chronic disease prevention to the World Health Organization; National Cancer Institute; National Governors Association; Health Canada; the Health Ministry of Israel; the Institute of Medicine; several U.S. Governors; the US Secretary of Health; and the FDA.

Dr. Katz serves as a reviewer of federal research grants for the NIH, the CDC, and AHRQ, as well as a number of international organizations. He is a peer reviewer for numerous leading medical journals. He is on the editorial advisory boards of The American Journal of Health Promotion; Prevention Magazine; Health; Men’s Health; Children’s Health; and Eating Well. In 2011, he was appointed Editor-in-Chief of the peer-reviewed journal, Childhood Obesity. He was nominated for the position of US Surgeon General in 2009 by the American College of Physicians, the American College of Preventive Medicine, and the Center for Science in the Public Interest, among others; and was the 2011 recipient of the Katharine Boucot Sturgis award from the American College of Preventive Medicine, the most prestigious award the College confers – awarded for illustrious career contributions to the field of Preventive Medicine. Also in 2011, he received the Lenna Frances Cooper Award from the American Dietetic Association for illustrious contributions to the field of nutrition. In 2012, Katz was named the first inductee into the MDPA Communicating Childhood Obesity Prevention and Policy Hall of Fame.

— Daniel Pomp, MS, PhD: Dr. Daniel Pomp is a Professor of Genetics, Nutrition, & Cell and Molecular Physiology in the School of Medicine and the Gillings School of Global Public Health at the University of North Carolina. He is a member of UNC’s Nutrition and Obesity Research Center, Carolina Center for Genome Science, Center for Integrated Systems Genomics, Lineberger Comprehensive Cancer Center, and Center for Environmental Health and Susceptibility.

Dr. Pomp studies the genetic architecture of complex traits, with an emphasis on obesity and body weight regulation. Using polygenic mouse models and high throughput approaches integrating genomics and physiology, he identifies genes that control predisposition to obesity, including components of energy balance such as caloric intake, basal metabolism and voluntary exercise. He studies how these genes interact with each other and with nutritional and therapeutic interventions, and how these combine to regulate an individual’s change in weight, fat and muscle content. Dr. Pomp also investigates polygenic and dietary obesity as risk factors for mammary and colon cancer susceptibility.

Dr. Pomp serves on the editorial board for several journals, including Physiological Genomics, Journal of Biomedicine and Biotechnology, Advances in Genomics and Gene Expression, and Mammalian Genome. Dr. Pomp’s research has been funded by the National Institute of Health, the National Science Foundation, the United States Department of Agriculture, and by a variety of sources in the biomedical and agricultural industries. He earned his Ph.D. in Animal Genetics from North Carolina State University, a Masters in Animal Breeding from the University of Wisconsin, and a BS in Animal Science from the Hebrew University of Jerusalem.

About GenoVive LLC
Founded in 2008, GenoVive, a division of Genvis Bio Group, LLC, based in New Orleans, LA, represents a new approach to weight loss and sustained healthy eating. GenoVive’s geneticists and food scientists developed customized, all-natural meal and exercise programs, featuring ideal combinations of macronutrients based on individual DNA. GenoVive’s flavorful and quality meals are made without additives and preservatives and consist of six days per week of daily meals including breakfast, lunch, dinner, snacks, beverages, and vitamin supplements. GenoVive is sold directly to the consumer at and by phone with convenient home delivery. Follow GenoVive on Twitter @myGenovive, Facebook at, and YouTube at

Comments are closed.

Connect With Us